Home > Insider Trading > Filing (0001179110-13-016432)

Filing Details

Accession Number:: 0001179110-13-016432
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-11-12 17:39:34
Reporting Period:: 2013-11-07

Filing Date:: 2013-11-12
Accepted Time:: 2013-11-12 17:39:34
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1578845	Actavis Plc	ACT	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1134996	A John King	1 Grand Canal Square, Docklands Dublin 2 L2 00000		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Disposition	2013-11-07	5,931	$156.38	0	No	4	S	Direct
Ordinary Shares	Disposition	2013-11-07	28,763	$156.43	187,884	No	4	S	Indirect	By Pandalena Limited
Ordinary Shares	Disposition	2013-11-07	1,000	$157.05	186,884	No	4	S	Indirect	By Pandalena Limited
Ordinary Shares	Disposition	2013-11-08	32,470	$155.41	154,414	No	4	S	Indirect	By Pandalena Limited
Ordinary Shares	Disposition	2013-11-08	89,767	$155.90	64,647	No	4	S	Indirect	By Pandalena Limited

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Indirect	By Pandalena Limited
No	4	S	Indirect	By Pandalena Limited
No	4	S	Indirect	By Pandalena Limited
No	4	S	Indirect	By Pandalena Limited

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.09 to $156.72, inclusive. The reporting person undertakes to provide Actavis plc, any security holder of Actavis plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price range set forth in footnote (1) of this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.00 to $156.99, inclusive. The reporting person undertakes to provide Actavis plc, any security holder of Actavis plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price range set forth in footnote (2) of this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.00 to $157.13, inclusive. The reporting person undertakes to provide Actavis plc, any security holder of Actavis plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price range set forth in footnote (3) of this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $154.63 to $155.62, inclusive. The reporting person undertakes to provide Actavis plc, any security holder of Actavis plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price range set forth in footnote (4) of this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.63 to $156.53, inclusive. The reporting person undertakes to provide Actavis plc, any security holder of Actavis plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price range set forth in footnote (5) of this Form 4.
The shares were previously reported as owned indirectly by the Reporting Person through Roanzo Limited. The shares were subsequently transferred to Pandalena Limited resulting in a change from one form of indirect ownership to another form of indirect ownership.